GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0071622
|
BP
|
regulation of granulocyte chemotaxis
|
Any process that modulates the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.
|
CAMK1D
|
GO:0071624
|
BP
|
positive regulation of granulocyte chemotaxis
|
Any process that increases the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.
|
S100A7
|
GO:0071625
|
BP
|
vocalization behavior
|
The behavior in which an organism produces sounds by a mechanism involving its respiratory system.
|
SRPX2,
DLG4,
NLGN4X,
NRXN1
|
GO:0071629
|
BP
|
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process
|
The chemical reactions and pathways resulting in the breakdown of misfolded proteins in the cytoplasm, which are targeted to cytoplasmic proteasomes for degradation.
|
RNF126
|
GO:0071636
|
BP
|
positive regulation of transforming growth factor beta production
|
Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta.
|
CD46,
PTGS2
|
GO:0071638
|
BP
|
negative regulation of monocyte chemotactic protein-1 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of monocyte chemotactic protein-1.
|
SOCS5,
APOD,
GSTP1,
NR1H4,
C1QTNF3
|
GO:0071639
|
BP
|
positive regulation of monocyte chemotactic protein-1 production
|
Any process that activates or increases the frequency, rate, or extent of production of monocyte chemotactic protein-1.
|
IL1A,
IL1B,
TWIST1,
ADIPOQ,
TRPV4
|
GO:0071642
|
BP
|
positive regulation of macrophage inflammatory protein 1 alpha production
|
Any process that activates or increases the frequency, rate, or extent of production of macrophage inflammatory protein 1 alpha.
|
TRPV4
|
GO:0071650
|
BP
|
negative regulation of chemokine (C-C motif) ligand 5 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.
|
IL10
|
GO:0071651
|
BP
|
positive regulation of chemokine (C-C motif) ligand 5 production
|
Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.
|
DDX3X,
MAVS,
TRPV4
|
GO:0071660
|
BP
|
positive regulation of IP-10 production
|
Any process that activates or increases the frequency, rate, or extent of production of IP-10.
|
MAVS
|
GO:0071663
|
BP
|
positive regulation of granzyme B production
|
Any process that activates or increases the frequency, rate, or extent of production of granzyme B.
|
CD244
|
GO:0071670
|
BP
|
smooth muscle cell chemotaxis
|
The directed movement of a smooth muscle cell in response to an external stimulus.
|
PDGFRB,
PARVA
|
GO:0071672
|
BP
|
negative regulation of smooth muscle cell chemotaxis
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell chemotaxis.
|
SLIT2,
GSTP1,
CORO1B
|
GO:0071673
|
BP
|
positive regulation of smooth muscle cell chemotaxis
|
Any process that activates or increases the frequency, rate, or extent of smooth muscle cell chemotaxis.
|
PDGFD
|
GO:0071674
|
BP
|
mononuclear cell migration
|
The movement of a mononuclear cell within or between different tissues and organs of the body.
|
LGALS3
|
GO:0071676
|
BP
|
negative regulation of mononuclear cell migration
|
Any process that decreases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
SLIT2
|
GO:0071677
|
BP
|
positive regulation of mononuclear cell migration
|
Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
TGFB1,
TNF,
LGALS3
|
GO:0071679
|
BP
|
commissural neuron axon guidance
|
The process in which the migration of an axon growth cone of a commissural neuron is directed to its target in the brain in response to a combination of attractive and repulsive cues.
|
NFIB,
NRP1,
VEGFA,
EPHB2,
DAG1
|
GO:0071681
|
BP
|
cellular response to indole-3-methanol
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an indole-3-methanol stimulus.
|
JUP,
CTNNA1,
CTNNB1,
BRCA1
|
GO:0071691
|
BP
|
cardiac muscle thin filament assembly
|
The aggregation, arrangement and bonding together of proteins to form the actin-based thin filaments of myofibrils in cardiac muscle.
|
NEBL
|
GO:0071701
|
BP
|
regulation of MAPK export from nucleus
|
Any process that modulates the frequency, rate or extent of the directed movement of a MAP kinase from the nucleus to the cytoplasm.
|
DNAJC27
|
GO:0071709
|
BP
|
membrane assembly
|
The aggregation, arrangement and bonding together of a set of components to form a membrane.
|
SPTBN1,
ANK3
|
GO:0071711
|
BP
|
basement membrane organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.
|
FLRT2,
SPINT2,
NID1,
MMP11,
NID2,
DAG1
|
GO:0071712
|
BP
|
ER-associated misfolded protein catabolic process
|
The chemical reactions and pathways resulting in the breakdown of misfolded proteins transported from the endoplasmic reticulum and targeted to cytoplasmic proteasomes for degradation.
|
TOR1A,
VCP,
UFD1L,
SDF2,
UGGT1,
POMT1
|
GO:0071726
|
BP
|
cellular response to diacyl bacterial lipopeptide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a diacylated bacterial lipopeptide stimulus.
|
TLR2,
CD14,
CD36
|
GO:0071727
|
BP
|
cellular response to triacyl bacterial lipopeptide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a triacylated bacterial lipopeptide stimulus.
|
TLR2,
CD14,
TLR1
|
GO:0071732
|
BP
|
cellular response to nitric oxide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
|
AIFM1,
CCNA2,
CDK2,
MT3,
FOXO1,
HNRNPD,
MTR
|
GO:0071733
|
BP
|
transcriptional activation by promoter-enhancer looping
|
The formation and maintenance of DNA loops that juxtapose the promoter and enhancer regions of RNA polymerase II-transcribed genes and activate transcription from an RNA polymerase II promoter.
|
RUVBL2
|
GO:0071763
|
BP
|
nuclear membrane organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear inner or outer membrane.
|
TOR1A,
TMEM43
|
GO:0071765
|
BP
|
nuclear inner membrane organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear inner membrane.
|
TARDBP
|
GO:0071773
|
BP
|
cellular response to BMP stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
SMAD9,
SPINT2,
BMP2,
BMP4,
BMP6,
ACVR2A,
BMPR1A,
DLX5,
ADAMTS12,
ACVR1,
SMAD4,
BMPR2,
RUNX2,
SFRP1,
GATA6,
HEYL,
ADAMTS7
|
GO:0071774
|
BP
|
response to fibroblast growth factor
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fibroblast growth factor stimulus.
|
PTH,
ELK1,
TNC,
IER2
|
GO:0071786
|
BP
|
endoplasmic reticulum tubular network organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endoplasmic reticulum (ER) tubular network. The ER tubular network is the ER part that that has membranes with high curvature in cross-section.
|
TMEM170A,
LNP,
REEP1,
RTN4
|
GO:0071787
|
BP
|
endoplasmic reticulum tubular network assembly
|
The aggregation, arrangement and bonding together of a set of components to form the endoplasmic reticulum (ER) tubular network. The ER tubular network is the ER part that comprises the membranes with high curvature in cross-section.
|
ARL6IP1,
RTN4
|
GO:0071799
|
BP
|
cellular response to prostaglandin D stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin D stimulus.
|
TNC,
AKR1C3,
PTGFR,
AKR1C2,
PTGDR
|
GO:0071800
|
BP
|
podosome assembly
|
The aggregation, arrangement and bonding together of a set of components to form a podosome, an actin-rich adhesion structure characterized by formation upon cell substrate contact and localization at the substrate-attached part of the cell.
|
SH3PXD2B,
FARP2,
BIN2
|
GO:0071803
|
BP
|
positive regulation of podosome assembly
|
Any process that activates or increases the rate or extent of podosome assembly.
|
TNF,
LCP1,
MAPK9,
ARHGEF5,
FSCN1
|
GO:0071805
|
BP
|
potassium ion transmembrane transport
|
A process in which a potassium ion is transported from one side of a membrane to the other.
|
KCNK1,
KCNK3,
CNGA1,
FXYD4,
KCNA1,
KCNMA1,
KCNH2,
PKD2,
KCNC3,
KCNJ11,
KCNG3,
KCNV2,
KCNE4,
SLC9A6,
KCNK17,
KCNK12,
KCNIP2,
TMEM38B,
SLC9A2,
KCNG1,
KCNK6
|
GO:0071806
|
BP
|
protein transmembrane transport
|
The directed movement of a protein across a membrane by means of some agent such as a transporter or pore.
|
AZGP1,
SEC61G,
NUTF2,
MCL1
|
GO:0071812
|
BP
|
positive regulation of fever generation by positive regulation of prostaglandin secretion
|
Any process that increases the rate or extent of fever generation via positive regulation of the frequency, rate or extent of the regulated release of a prostaglandin from a cell.
|
TNFSF11,
TNFRSF11A
|
GO:0071816
|
BP
|
tail-anchored membrane protein insertion into ER membrane
|
A process of protein insertion into the endoplasmic reticulum (ER) membrane in which a tail-anchored (TA) transmembrane protein is incorporated into an endoplasmic reticulum (ER) membrane. TA transmembrane protein, also named type II transmembrane proteins, contain a single C- terminal transmembrane region.
|
WRB
|
GO:0071838
|
BP
|
cell proliferation in bone marrow
|
The multiplication or reproduction of cells, resulting in the expansion of a cell population in the bone marrow.
|
ACE
|
GO:0071847
|
BP
|
TNFSF11-mediated signaling pathway
|
A series of molecular signals initiated by the binding of tumor necrosis factor ligand superfamily member 11 (TNFSF11) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
TNFSF11,
TNFRSF11A
|
GO:0071848
|
BP
|
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling
|
Any TNFSF11-mediated signaling process that increases the rate, frequency, or extent of the ERK1 and ERK2 cascade.
|
TNFSF11,
TNFRSF11A
|
GO:0071850
|
BP
|
mitotic cell cycle arrest
|
The process in which the mitotic cell cycle is halted during one of the normal phases (G1, S, G2, M).
|
GADD45A,
DUSP1,
CDKN1A,
CDKN1B,
MAGI2,
MCPH1,
GADD45GIP1,
PNPT1,
RGCC,
CDC14A
|
GO:0071864
|
BP
|
positive regulation of cell proliferation in bone marrow
|
A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.
|
PTH,
IL6,
MEF2C
|
GO:0071866
|
BP
|
negative regulation of apoptotic process in bone marrow
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.
|
PTH,
HSPD1
|
GO:0071870
|
BP
|
cellular response to catecholamine stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution.
|
GNB1,
NR4A3
|
GO:0071871
|
BP
|
response to epinephrine
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.
|
PENK,
PPARGC1A
|
GO:0071872
|
BP
|
cellular response to epinephrine stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.
|
PRKACA,
SRD5A1,
ATP2B4,
SNCA,
STAR,
PDE4D,
ADIPOQ,
SIRT2,
RYR2
|
GO:0071873
|
BP
|
response to norepinephrine
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.
|
PPARGC1A
|
GO:0071874
|
BP
|
cellular response to norepinephrine stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.
|
APP
|
GO:0071875
|
BP
|
adrenergic receptor signaling pathway
|
A series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
|
PDE4D,
AKAP13
|
GO:0071877
|
BP
|
regulation of adrenergic receptor signaling pathway
|
Any process that modulates the frequency, rate or extent of an adrenergic receptor signaling pathway activity. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
|
RGS2
|
GO:0071879
|
BP
|
positive regulation of adrenergic receptor signaling pathway
|
Any process that activates or increases the frequency, rate or extent of the adrenergic receptor protein signaling pathway. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
|
ARRDC3
|
GO:0071880
|
BP
|
adenylate cyclase-activating adrenergic receptor signaling pathway
|
The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
|
ADCY9,
ADRB2,
ADRB1,
ADRB3,
ADRA2B,
ADRA1D,
ADRA1A,
ADRA1B
|
GO:0071883
|
BP
|
activation of MAPK activity by adrenergic receptor signaling pathway
|
The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, followed by the activation of a MAP kinase.
|
ADRA2B,
AKAP13
|
GO:0071888
|
BP
|
macrophage apoptotic process
|
Any apoptotic process in a macrophage, a mononuclear phagocyte present in a variety of tissues.
|
CTSL
|
GO:0071893
|
BP
|
BMP signaling pathway involved in nephric duct formation
|
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to nephric duct formation.
|
BMP4
|
GO:0071894
|
BP
|
histone H2B conserved C-terminal lysine ubiquitination
|
A histone ubiquitination process in which a ubiquitin monomer is added to a conserved lysine residue in the C-terminus of histone H2B. The conserved lysine residue is K119 in fission yeast, K123 in budding yeast, or K120 in mammals.
|
WAC
|
GO:0071895
|
BP
|
odontoblast differentiation
|
The process in which a relatively unspecialized cell of neural crest origin acquires the specialized features of an odontoblast, a cell on the outer surface of the dental pulp whose biological function is the creation of dentin.
|
FAM20C
|
GO:0071896
|
BP
|
protein localization to adherens junction
|
Any process in which a protein is transported to, and/or maintained at the adherens junction.
|
DSP,
DLG5
|
GO:0071897
|
BP
|
DNA biosynthetic process
|
The cellular DNA metabolic process resulting in the formation of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one.
|
TK2,
POLQ,
TK1,
TYMS,
LIG1,
CTGF,
PHB,
CENPF,
POLG,
POLA2,
PAPD5,
MYBBP1A,
POLE4,
POLE3,
CHRAC1
|
GO:0071899
|
BP
|
negative regulation of estrogen receptor binding
|
Any process that stops, prevents, or reduces the frequency, rate or extent of estrogen receptor binding, interacting selectively with an estrogen receptor.
|
RUVBL2
|
GO:0071901
|
BP
|
negative regulation of protein serine/threonine kinase activity
|
Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.
|
LRP5,
H2AFY,
LRP6,
HSPB1,
SFN,
CDKN2B,
CDKN2C,
CDKN1C,
CIB1,
WNK1,
PYCARD
|
GO:0071902
|
BP
|
positive regulation of protein serine/threonine kinase activity
|
Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.
|
SPRY2,
IGF2,
CSF1R,
HSP90AB1,
RALB,
ACSL1,
MAP2K2,
SNCA,
RHOA,
CALM2,
MAP2K1,
STK4,
CAMK1,
STK11,
EZH2,
SLC27A1,
ALS2,
CIB1,
PDCD10,
CAB39
|
GO:0071907
|
BP
|
determination of digestive tract left/right asymmetry
|
Determination of the asymmetric location of various parts of the digestive tract with respect to the left and right halves of the organism. The digestive tract is the anatomical structure through which food passes and is processed.
|
CCDC103
|
GO:0071908
|
BP
|
determination of intestine left/right asymmetry
|
Determination of the asymmetric location of the intestine loops with respect to the left and right halves of the organism.
|
NPHP3
|
GO:0071909
|
BP
|
determination of stomach left/right asymmetry
|
Determination of the asymmetric location of the stomach with respect to the left and right halves of the organism.
|
NPHP3
|
GO:0071910
|
BP
|
determination of liver left/right asymmetry
|
Determination of the asymmetric location of the liver with respect to the left and right halves of the organism.
|
PKD2,
NPHP3
|
GO:0071918
|
BP
|
urea transmembrane transport
|
The process in which urea, the water-soluble compound H2N-CO-NH2, is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
|
AQP9,
SLC14A1,
AQP3
|
GO:0071922
|
BP
|
regulation of cohesin loading
|
Any process that modulates the frequency, rate or extent of a process in which a cohesin complex is transported to, or maintained at, a part of a chromosome that is organized into chromatin.
|
RB1,
WAPL,
CDCA5,
HDAC8
|
GO:0071930
|
BP
|
negative regulation of transcription involved in G1/S transition of mitotic cell cycle
|
Any process that stop, prevents or decreases transcription as part of the G1/S transition of the mitotic cell cycle.
|
RB1,
E2F1
|
GO:0071931
|
BP
|
positive regulation of transcription involved in G1/S transition of mitotic cell cycle
|
Any process that activates or increases transcription as part of the G1/S transition of the mitotic cell cycle.
|
ZPR1,
ID2
|
GO:0071934
|
BP
|
thiamine transmembrane transport
|
The directed movement of thiamine across a membrane into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Thiamine is vitamin B1, a water soluble vitamin present in fresh vegetables and meats, especially liver.
|
SLC19A2
|
GO:0071947
|
BP
|
protein deubiquitination involved in ubiquitin-dependent protein catabolic process
|
The removal of one or more ubiquitin groups from a protein as part of a process of ubiquitin-dependent protein catabolism.
|
TNFAIP3,
OTUD7B,
ZRANB1
|
GO:0071951
|
BP
|
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA
|
The modification process that results in the conversion of methionine charged on a tRNA(fMet) to N-formyl-methionine-tRNA(fMet).
|
MTFMT
|
GO:0071954
|
BP
|
chemokine (C-C motif) ligand 11 production
|
The appearance of chemokine (C-C motif) ligand 11 (CCL11, also known as eotaxin-1) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
TNFSF4
|
GO:0071955
|
BP
|
recycling endosome to Golgi transport
|
The directed movement of substances from recycling endosomes to the Golgi.
|
TBC1D14
|
GO:0071962
|
BP
|
mitotic sister chromatid cohesion, centromeric
|
The cell cycle process in which centromeres of sister chromatids are joined during mitosis.
|
NAA50
|
GO:0071973
|
BP
|
bacterial-type flagellum-dependent cell motility
|
Cell motility due to the motion of one or more bacterial-type flagella. A bacterial-type flagellum is a motor complex composed of an extracellular helical protein filament coupled to a rotary motor embedded in the cell envelope.
|
DRC1,
DNAAF2
|
GO:0071976
|
BP
|
cell gliding
|
Cell motility that results in the smooth movement of a cell along a solid surface.
|
MYO1G
|
GO:0071985
|
BP
|
multivesicular body sorting pathway
|
A vesicle-mediated transport process in which transmembrane proteins are ubiquitylated to facilitate their entry into luminal vesicles of multivesicular bodies (MVBs); upon subsequent fusion of MVBs with lysosomes or vacuoles, the cargo proteins are degraded.
|
RAB27B,
RAB27A,
EXPH5,
SYTL4,
VTA1
|
GO:0072001
|
BP
|
renal system development
|
The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.
|
BMP4,
ITGB4,
ITGA6,
EMX2,
PTCH1,
NUP93,
SOX17,
SEC63
|
GO:0072006
|
BP
|
nephron development
|
The process whose specific outcome is the progression of the nephron over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.
|
ITGA3,
JAG1
|
GO:0072011
|
BP
|
glomerular endothelium development
|
The process whose specific outcome is the progression of the glomerular endothelium over time, from its formation to the mature structure. The glomerular endothelium is an epithelial tissue that covers the internal surfaces of the glomerulus.
|
PECAM1
|
GO:0072012
|
BP
|
glomerulus vasculature development
|
The biological process whose specific outcome is the progression of a glomerulus vasculature from an initial condition to its mature state. This process begins with the formation of the glomerulus vasculature and ends with the mature structure. The glomerulus vasculature is composed of the tubule structures that carry blood or lymph in the glomerulus.
|
ANGPT2,
HES1,
ANGPT1
|
GO:0072014
|
BP
|
proximal tubule development
|
The process whose specific outcome is the progression of the proximal tubule over time, from its formation to the mature structure. In mammals, the proximal tubule is a nephron tubule that connects Bowman's capsule to the descending thin limb of the loop of Henle. It has a brush border epithelial morphology.
|
HEYL
|
GO:0072015
|
BP
|
glomerular visceral epithelial cell development
|
The process whose specific outcome is the progression of a glomerular visceral epithelial cell over time, from its formation to the mature structure. A glomerular visceral epithelial cell is a specialized epithelial cell that contains feet that interdigitate with the feet of other glomerular epithelial cells.
|
BMP4,
IQGAP1,
JAG1,
MYO1E,
MAGI2,
NUP93
|
GO:0072017
|
BP
|
distal tubule development
|
The process whose specific outcome is the progression of the distal tubule over time, from its formation to the mature structure. In mammals, the distal tubule is a nephron tubule that begins at the macula densa and extends to the connecting tubule.
|
NOTCH1,
JAG1
|
GO:0072033
|
BP
|
renal vesicle formation
|
The developmental process pertaining to the initial formation of the renal vesicle from condensed mesenchymal cells. The renal vesicle is the primordial structure of the nephron epithelium, and is formed by the condensation of mesenchymal cells.
|
CTNNB1
|
GO:0072034
|
BP
|
renal vesicle induction
|
Signaling at short range between cells of the ureteric bud terminus and the kidney mesenchyme that positively regulates the formation of the renal vesicle.
|
SOX9,
SOX8
|
GO:0072044
|
BP
|
collecting duct development
|
The process whose specific outcome is the progression of a collecting duct over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. It is the final common path through which urine flows before entering the ureter and then emptying into the bladder.
|
NOTCH1
|
GO:0072049
|
BP
|
comma-shaped body morphogenesis
|
The process in which the comma-shaped body is generated and organized. The comma-shaped body is the precursor structure to the S-shaped body that contributes to the morphogenesis of the nephron.
|
HES1
|
GO:0072050
|
BP
|
S-shaped body morphogenesis
|
The process in which the S-shaped body is generated and organized. The S-shaped body is the successor of the comma-shaped body that contributes to the morphogenesis of the nephron.
|
HES1
|
GO:0072053
|
BP
|
renal inner medulla development
|
The process whose specific outcome is the progression of the renal inner medulla over time, from its formation to the mature structure. The renal inner medulla is unique to mammalian kidneys and is the innermost region of the mammalian kidney.
|
CTNNB1
|
GO:0072054
|
BP
|
renal outer medulla development
|
The process whose specific outcome is the progression of the renal outer medulla over time, from its formation to the mature structure. The renal outer medulla is the region of the kidney that lies between the renal cortex and the renal inner medulla.
|
CTNNB1
|
GO:0072061
|
BP
|
inner medullary collecting duct development
|
The process whose specific outcome is the progression of the inner medullary collecting duct over time, from its formation to the mature structure. The inner medullary collecting duct is the portion of the collecting duct that lies in the renal inner medulla.
|
AKR1B1
|
GO:0072070
|
BP
|
loop of Henle development
|
The process whose specific outcome is the progression of the loop of Henle over time, from its formation to the mature structure. The loop of Henle is a nephron tubule that connects the proximal convoluted tubule to the distal convoluted tubule.
|
JAG1
|